Correlation Between Delcath Systems and INVO Bioscience

Can any of the company-specific risk be diversified away by investing in both Delcath Systems and INVO Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delcath Systems and INVO Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Delcath Systems and INVO Bioscience, you can compare the effects of market volatilities on Delcath Systems and INVO Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delcath Systems with a short position of INVO Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delcath Systems and INVO Bioscience.

Diversification Opportunities for Delcath Systems and INVO Bioscience

0.33

Correlation Coefficient

Delcath Systems  INVO Bioscience

Weak diversification

The 3 months correlation between Delcath and INVO is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Delcath Systems and INVO Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INVO Bioscience and Delcath Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delcath Systems are associated (or correlated) with INVO Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INVO Bioscience has no effect on the direction of Delcath Systems i.e., Delcath Systems and INVO Bioscience go up and down completely randomly.

Pair Corralation between Delcath Systems and INVO Bioscience

Given the investment horizon of 90 days Delcath Systems is expected to generate 1.61 times less return on investment than INVO Bioscience. In addition to that, Delcath Systems is 1.03 times more volatile than INVO Bioscience. It trades about 0.13 of its total potential returns per unit of risk. INVO Bioscience is currently generating about 0.21 per unit of volatility. If you would invest  79.00  in INVO Bioscience on September 5, 2024 and sell it today you would earn a total of  5.00  from holding INVO Bioscience or generate 6.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	36.36%
Values	Daily Returns

Delcath Systems  vs.  INVO Bioscience

Delcath Systems

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Delcath Systems are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Delcath Systems demonstrated solid returns over the last few months and may actually be approaching a breakup point.

INVO Bioscience

Risk-Adjusted Performance

0 of 100

Insignificant

Over the last 90 days INVO Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Delcath Systems and INVO Bioscience

The main advantage of trading using opposite Delcath Systems and INVO Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delcath Systems position performs unexpectedly, INVO Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will offset losses from the drop in INVO Bioscience's long position.

The idea behind Delcath Systems and INVO Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.